Nav: Home

New organ culture system reveals effects of BPA exposure on fetal mammary glands

January 24, 2017

BOSTON (January 24, 2017)--A new organ culture system developed by scientists from Tufts University School of Medicine now enables tests of the direct effects of chemical exposure, including estrogen and estrogen-like substances, on developing fetal mouse mammary tissue. Previous laboratory models could only measure the joint effect of chemicals and maternal estrogen.

Analyses of the initial chemical investigated--bisphenol-A (BPA), an estrogen-like compound found in plastics, including food and beverage containers--revealed that BPA significantly and directly increased tissue growth in the absence of natural estrogens, when given at doses comparable to that of human exposure to BPA. Prior research in animal models has suggested that changes in fetal mammary tissue may be linked to increased risk of breast cancer in adulthood.

The study was published in Scientific Reports on Jan. 19.

"Our findings show that BPA, given at low doses, acts directly on the fetal mammary gland and causes similar effects observed in other animal model studies," said senior study author Ana Soto, M.D., professor in the Department of Integrative Physiology and Pathobiology at TUSM. "Because these very low, environmentally relevant levels of BPA directly affect mammary gland development, this in turn may increase the propensity to develop cancer during adult life."

"This novel bioassay enables us to answer questions that could not be addressed previously, including how these chemicals may cause abnormal organ development, a feature that is known to increase the risk of developing several diseases later in adulthood," said co-senior author Carlos Sonnenschein, M.D., a professor in the Department of Integrative Physiology and Pathobiology at TUSM.

According to a study considered representative of exposures in the U.S. conducted by the Centers for Disease Control and Prevention, BPA, which is used in the manufacture of plastics, has been found in the urine of 93 percent of Americans aged six or older. Previous research based in animal models has found that BPA, which mimics the activity of estrogen, can cause a wide range of disorders in fetuses and newborns.

Fetal exposure to BPA has been shown to alter and impair mammary gland development in mice, causing changes to lactation and increasing the risk of mammary cancer in adulthood. Until now, however, it was impossible to determine whether the observed effects of BPA were caused by its estrogen-like activity or by another mechanism, because experiments would interfere with maternal estrogens and could interrupt pregnancy.

In the current study, a team led by Soto and Sonnenschein and lead study author Lucia Speroni, PhD, research associate at TUSM, developed a novel model in which the entire mammary gland is isolated from embryonic mice and cultured in laboratory conditions similar to those in its natural environment. In the absence of maternal estrogen, this model enables investigation of estrogen and estrogen-like chemical exposure on live, developing fetal mammary tissue.

Using their new model, the team found that BPA affects fetal mammary tissue differently depending on the dose. When given at environmentally relevant levels similar to that of human exposure (1 nanomolar), BPA significantly increased the growth and branching of mammary ducts. When given at much higher levels (1 micromolar), BPA displayed the opposite activity and significantly inhibited growth.

The effect of BPA exposure was not seen when the tissue was treated with fulvestrant, an anti-estrogen compound that blocks nuclear estrogen receptors. This class of estrogen receptors has the ability to control the expression of genomic DNA. According to the authors, this finding suggests that BPA works through these receptors, but additional research is needed to reveal the precise mechanisms.

The team also tested the effect of estradiol, the natural estrogen produced by the ovaries, and found that it inhibited mammary tissue growth in a dose-dependent manner. Treatment of tissue with fulvestrant had no effect on preventing changes caused by estradiol, suggesting that it works through a separate mechanism than BPA. By revealing functional differences between the effect of estradiol and BPA, the findings illustrate the complexity of hormone regulation in organs, write the authors.

The development of this new ex-vivo model now enables further exploration of the mechanisms by which BPA and estrogen affect developing fetal mammary tissue, as well as many other chemicals that could not be investigated before. By isolating the tissue and removing many confounding factors that are present in other models, the team hopes to gain a clearer understanding of how exposure to common hormone-modulating chemicals affects fetal development and disease in adulthood.

"We have developed an ex-vivo culture method of the fetal mammary gland, where the action of hormone disruptors such as BPA can be tested at a critical window of exposure," Speroni said. "This represents a novel approach to study the effects of hormones and hormonally-active chemicals on the developing fetal mammary tissue outside the organism."
Soto and Sonnenschein are faculty in the Cell, Molecular & Developmental Biology and Genetics programs at the Sackler School. Soto is a former Blaise Pascal Chair in residence at the Ecole Normale Superieure in Paris, France. Additional authors include Skylar A. Klager and Cheryl M. Schaeberle of Tufts University School of Medicine, and Maria Voutilainen and Marja L. Mikkola of the University of Helsinki, Finland.

The study was supported by the National Institute of Environmental Health Sciences of the National Institutes of Health (award ES08314) and the Art beCAUSE Breast Cancer Foundation.

Speroni et al. "New insights into fetal mammary gland morphogenesis: differential effects of natural and environmental estrogens." Scientific Reports (2017). DOI: 10.1038/srep40806.

About Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences

Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences are international leaders in medical and population health education and advanced research. Tufts University School of Medicine emphasizes rigorous fundamentals in a dynamic learning environment to educate physicians, scientists, and public health professionals to become leaders in their fields. The School of Medicine and the Sackler School are renowned for excellence in education in general medicine, the biomedical sciences, and public health, as well as for innovative research at the cellular, molecular, and population health level. The School of Medicine is affiliated with six major teaching hospitals and more than 30 health care facilities. Tufts University School of Medicine and the Sackler School undertake research that is consistently rated among the highest in the nation for its effect on the advancement of medical and prevention science.

Tufts University, Health Sciences Campus

Related Breast Cancer Articles:

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.
Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
More Breast Cancer News and Breast Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at